Neurological Intensive Care for Acute Spinal Cord Injury Patients
Journal of Neurointensive Care · 2018
DOI: 10.32587/jnic.2018.00045 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neurointensive Care, 2018. Verfasst von Junseok W Hur und 4 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Korea University, National Research Foundation of Korea, Ministry of Education, Science and Technology.
Themen: Intensivpflege
Abstract (Originalsprache)
The spinal cord injury (SCI) patients suffer various medical conditions at early period after injury.Methylprednisolone could be administrated for neurologic recovery but the potential side effects could be carefully considered.Besides limb motor and sensory deficits, SCI could affect various respiratory muscles as diaphragm, chest wall, and abdomen which leads to respiratory failure and mechanical ventilation.Sympathetic nerve denervation could lead hypotension and bradycardia.Volume supplement and cardiovascular constrictor could be considered.Prevention and treatment of pressure sore are essential and active pain control should be started from the intensive care unit.
Förderung
- Korea University
- National Research Foundation of Korea
- Ministry of Education, Science and Technology
Zitieren
APA
Hur, J. W., Park, D., Lee, J., Cho, T., & Park, J. (2018). Neurological Intensive Care for Acute Spinal Cord Injury Patients. Journal of Neurointensive Care. https://doi.org/10.32587/jnic.2018.00045
Vancouver
Hur JW, Park D, Lee J, Cho T, Park J. Neurological Intensive Care for Acute Spinal Cord Injury Patients. Journal of Neurointensive Care. 2018. doi:10.32587/jnic.2018.00045
BibTeX
@article{Hur2018,
author = {Hur, Junseok W and Park, Dong-Hyuk and Lee, Jang-Bo and Cho, Tai-Hyoung and Park, Jung-Yul},
title = {Neurological Intensive Care for Acute Spinal Cord Injury Patients},
journal = {Journal of Neurointensive Care},
year = {2018},
doi = {10.32587/jnic.2018.00045}
}
EUVIMED